is fda stopping semaglutide FBI warns about counterfeit weight loss drugs Semaglutide FDA Approval vs Compounded

These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease

Phase 3 monotherapy available Feature Expected GI burden Cagrilintide + Retatrutide Very high CagriSema (Cag + Sema) High Retatrutide Alone High Feature Dysesthesia risk Cagrilintide + Retatrutide Yes (retatrutide component) CagriSema (Cag + Sema) No Retatrutide Alone Yes Feature Injections per week Cagrilintide + Retatrutide 2 (separate) or 1 (pre-blend) CagriSema (Cag + Sema) 1 or 2 Retatrutide Alone 1 Feature Regulatory status Cagrilintide + Retatrutide Neither approved

The BPC-157 peptide aids in producing angiogenic growth factors like FGF, TGF-b, and VEGF

According to the manufacturers instructions, Ozempic should be refrigerated between 36F and 46F (2C and 8C) before its initial use

Meanwhile, in India, several companies obtained early approval for generic replacements and began selling them the day the patents expired

Some insurers require 6 months of documented failed weight loss attempts with lifestyle modifications before approving these compounds